Bacteria-Based Nanoprobes for Cancer Therapy.
Ontology highlight
ABSTRACT: Surgical removal together with chemotherapy and radiotherapy has used to be the pillars of cancer treatment. Although these traditional methods are still considered as the first-line or standard treatments, non-operative situation, systemic toxicity or resistance severely weakened the therapeutic effect. More recently, synthetic biological nanocarriers elicited substantial interest and exhibited promising potential for combating cancer. In particular, bacteria and their derivatives are omnipotent to realize intrinsic tumor targeting and inhibit tumor growth with anti-cancer agents secreted and immune response. They are frequently employed in synergistic bacteria-mediated anticancer treatments to strengthen the effectiveness of anti-cancer treatment. In this review, we elaborate on the deve
SUBMITTER: Lu Y
PROVIDER: S-EPMC10821665 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature
ACCESS DATA